Arena Blog

Navigating the 510(k) Clearance and PMA Approval Process

linked-in icon twitter-icon facebook-icon

first 501KIntroduction

There are two main paths that medical device manufacturers can use to bring moderate- and high-risk devices to market with the FDA’s permission: through submittal of a premarket approval (PMA) request or 510(k) application.

Submitting a PMA application is a more extensive approach, requiring substantial evidence that provides “reasonable assurance that the device is safe and effective” through methods like clinical trials, and results in FDA “approval.” This process is reserved for high-risk Class III medical devices.

On the other hand, the 510(k) process is shorter and less costly, and results in FDA “clearance.” Applying for a 510(k) assumes a substantial equivalent, or “predicate” device, can be clearly identified. While there is no specific 510(k) form, 21 CFR 807 Subpart E details clear requirements regarding design, development, and documentation specifications for a 510(k) submission. As a result of this transparency, medical device companies can face drastic consequences if they fail to adhere to these detailed submittal requirements.

The product-centric advantage

Regardless of the approval route a device requires, the premarket submission process can be strenuous. Even the abbreviated 510(k) application requires about 25 types of documents that can result in hundreds-to-thousands of pages of text and images. Despite the grueling nature of these applications, adopting a product-centric approach throughout the new product development (NPD) period facilitates a smoother premarket notification process for medical device companies.

Quality Product RecordLinking to the product record—which includes the product’s bill of material (BOM) and is often comprised of multiple levels of mechanical, electrical, and software components; assembly and test procedures; and other associated documents critical for classifying the device—is a pivotal feature for identifying a predicate device if needed, and for presenting correct and accurate documentation for either submittal process. Additionally, eliminating disconnects between product design, test engineering, quality, and supply chain teams streamlines the submittal process and can aid companies seeking to demonstrate substantial equivalence to a predicate device.

Missing a step at any point along the premarket application path or failing to update the application with substantial product changes not only delays a product’s time to market but, in extreme cases, can result in a company shutdown due to an unmarketable product. As a result, the premarket period is a critical time for organization and communication across both product and quality teams.

How Arena can help

Arena provides a product-centric QMS solution that provides a holistic view of the entire finished device by tying quality and regulatory events to the product’s relational BOM and its revision history.

During the pre-submittal period, Arena offers organizations a solution to identify and gather the pre-submittal tasks and deliverables while providing an electronic collaboration tool that will capture development and verification activity. After submission, Arena helps companies by offering configurable templates that can be generated to address 510(k) updates and tasks that identify and track update actions. In addition, Arena can be utilized to identify and capture registration and listing requirements by individual markets.

Managing premarket approvals, as well as postmarket surveillance, with Arena not only updates product records in real-time, but also helps organize application and post-submittal documentation to ensure a smooth compliance journey for the company. 

Conclusion

Navigating 510(k) clearance or PMA approval can be riddled with obstacles and slow time-to-market to a frustrating pace. However, by adopting a product-centric approach, you can manage your premarket submittal process smoothly and with confidence.

FDA Audit ChallengesAre you struggling to aggregate your product records, or dreading the arrival of a premarket application or postmarket study? What specific challenges do you face? Let us know how we can help you deliver high-quality products to market faster and more effectively.

Sources:

About the Author

Sherry Dickson
Sherry Dickson

Sherry Dickson is a Senior Solution Consultant for Arena Solutions with 30 years of PLM, QMS, and ERP experience working in the medical device and high tech industries. Sherry has ...

Read More